Skip to main content
Log in

Serum magnesium, calcium, phosphate and PTH following long-term beta-blockade in ischaemic heart disease

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

In 40 patients with ischaemic heart disease the serum levels of magnesium, parathyroid hormone (PTH), phosphate, calcium, and ionized calcium remained unchanged and within normal limits following treatment for 12 months with alprenolol (n=20) or placebo (n=20). No changes occurred during a 2 week withdrawal period. The clinical implication is that the non-cardioselective betablocker alprenolol can be given to patients with ischaemic heart disease without the risk of inducing potentially cardiotoxic disturbances in serum magnesium and serum calcium levels. Whether this applies to cardioselective beta-blockers remains to be established.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Rasmussen Sandvad H, McNair P, Nørregard P, Backer V, Lindeneg O, Balslev S (1986) Intravenous magnesium in acute myocardial infarction. Lancet 1: 234–236

    Google Scholar 

  2. Morton BC, Nair RC, Smith FM, McKibbon TG, Poznanski WJ (1984) Magnesium therapy in acute myocardial infarction — a double-blind study. Magnesium 3: 346–352

    Google Scholar 

  3. Kukreja SC, Hargis GK, Bowser EN, Henderson WJ, Fisherman EW, Williams GA (1975) Role of adrenergic stimuli in parathyroid hormone secretion in man. J Clin Endocrinol Metab 40: 478–481

    Google Scholar 

  4. Caro JF, Castro JH, Glennon JA (1979) Effect of long-term propranolol administration on parathyroid hormone and calcium concentration in primary hyperparathyroidism. Ann Int Med 91: 740–741

    Google Scholar 

  5. Kayser L, Perrild H, Fogh-Andersen N, Mølholm Hansen J (1987) Hyperphosphataemi during beta-adrenoceptor blockade with acebutolol, oxprenolol, pindolol and timolol. Acta Med Scand 222: 143–146

    Google Scholar 

  6. Andersen MP, Bechsgard P, Frederiksen J, Hansen DA, Jürgensen HJ, Nielsen B, Pedersen F, Pedersen-Bjerregard O, Rasmussen SL (1979) Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results. Lancet 2: 865–868

    Google Scholar 

  7. Fogh-Andersen N, Hedegard L, Thode J, Siggaard-Andersen O (1984) Sex-dependent relation between ionized calcium and blood pressure. Clin Chem 30: 116–118

    Google Scholar 

  8. Fogh-Andersen N, Ladefoged J, Møller-Petersen J (1984) Renal and hepatic extraction of carboxyterminal immunoreactive parathyrin in normal man. J Clin Chem Clin Biochem 22: 479–482

    Google Scholar 

  9. Ljunghall S, Rudberg C, Åkershon G, Wide L (1982) Effects of beta-adrenergic blockade on serum parathyroid hormone in normal subjects and patients with primary hyperparathyroidism. Acta Med Scand 211: 27–30

    Google Scholar 

  10. Coevuet B, Desplau C, Sebert JL et al. (1980) Effect of propranolol and metoprolol on parathyroid hormone and calcitonin secretion in uraemic patients. Br Med J 280: 1344–1346

    Google Scholar 

  11. Murchison L, How J, Bewsher PD (1979) Comparison of propranolol and metoprolol in the management of hyperthyroidism. Br J Clin Pharmacol 8: 581–587

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perrild, H., Jessen-Jürgensen, H., Pedersen, F. et al. Serum magnesium, calcium, phosphate and PTH following long-term beta-blockade in ischaemic heart disease. Eur J Clin Pharmacol 34, 299–301 (1988). https://doi.org/10.1007/BF00540959

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00540959

Key words

Navigation